MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

Search

Pfizer

Closed

SectorHealthcare

27.08 -0.44

Overview

Share price change

24h

Current

Min

26.63

Max

27.22

Key metrics

By Trading Economics

Income

-45M

2.9B

Sales

938M

15B

P/E

Sector Avg

12.553

35.739

EPS

0.51

Dividend yield

7.15

Profit margin

19.982

Employees

81,000

EBITDA

266M

5.3B

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+4.85% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

7.15%

3.08%

Next Earnings

4 Nov 2025

Next Dividend date

1 Dec 2025

Next Ex Dividend date

7 Nov 2025

Market Stats

By TradingEconomics

Market Cap

1.8B

136B

Previous open

27.52

Previous close

27.08

News Sentiment

By Acuity

46%

54%

140 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Pfizer Chart

Past performance is not a reliable indicator of future results.

Related News

1 Oct 2025, 08:54 UTC

Major Market Movers

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

30 Sept 2025, 15:07 UTC

Major Market Movers

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

22 Sept 2025, 14:54 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

22 Sept 2025, 11:51 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 Sept 2025, 11:09 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

22 Sept 2025, 10:13 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

22 Sept 2025, 07:42 UTC

Acquisitions, Mergers, Takeovers

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

5 Aug 2025, 11:34 UTC

Earnings

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

22 Sept 2025, 15:17 UTC

Acquisitions, Mergers, Takeovers

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

22 Sept 2025, 13:43 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 Sept 2025, 11:26 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

22 Sept 2025, 11:26 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

22 Sept 2025, 10:48 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

22 Sept 2025, 10:47 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

22 Sept 2025, 10:46 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

22 Sept 2025, 10:45 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

22 Sept 2025, 10:45 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

22 Sept 2025, 09:12 UTC

Hot Stocks

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

5 Aug 2025, 20:44 UTC

Earnings

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 Aug 2025, 18:20 UTC

Earnings

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 Aug 2025, 18:17 UTC

Earnings

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 Aug 2025, 16:04 UTC

Market Talk

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5 Aug 2025, 15:25 UTC

Earnings

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 Aug 2025, 13:56 UTC

Earnings

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 Aug 2025, 11:43 UTC

Earnings

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5 Aug 2025, 11:27 UTC

Earnings

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 Aug 2025, 10:57 UTC

Earnings

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5 Aug 2025, 10:55 UTC

Earnings

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 Aug 2025, 10:53 UTC

Earnings

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5 Aug 2025, 10:51 UTC

Earnings

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Peer Comparison

Price change

Pfizer Forecast

Price Target

By TipRanks

4.85% upside

12 Months Forecast

Average 28.53 USD  4.85%

High 34 USD

Low 24 USD

Based on 17 Wall Street analysts offering 12 month price targets forPfizer - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

17 ratings

4

Buy

12

Hold

1

Sell

Technical Score

By Trading Central

22.855 / 23.85Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

140 / 371 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat